FlowBeams, the creator of the BoldJet needle-free injection technology, is poised to revolutionize healthcare and dermatology. Unveiled at CES 2025, BoldJet eliminates the pain of traditional injections, addressing issues like needle phobia and needlestick injuries. With an estimated 16 billion single-use syringes discarded annually, BoldJet provides a sustainable alternative by using laser-induced cavitation to create fast, microfluidic jets that deliver medications and vaccines with precision. This approach reduces waste, enhances safety, and eliminates the need for costly medical training. The technology promises to make injections safer, more efficient, and environmentally friendly, with potential applications in both medical and cosmetic fields.
FlowBeams has developed the world’s first affordable, laser-based, needle-free injection technology, BoldJet, which is set to revolutionize healthcare and dermatology. The solution, uses laser-induced cavitation to generate precise microfluidic jets that deliver liquid directly into the skin, eliminating the need for traditional needles. The technology offers a virtually painless, minimally invasive solution for medical injections, such as vaccines and insulin, as well as aesthetic procedures like Botox® and dermal fillers. By targeting superficial skin layers with high precision, BoldJet ensures accurate, effective treatments with reduced operational costs and minimal waste.
The device also tackles significant global challenges. According to the CDC, many people suffer from needle phobia, leading to delayed or avoided injections. BoldJet’s needle-free approach is poised to reduce these fears, enabling timely treatments. Additionally, it helps combat the environmental issue of single-use syringes and needles, with an estimated 32 billion syringes and needles discarded annually. The technology also addresses the problem of needlestick injuries, which affect healthcare workers worldwide, by eliminating the need for traditional needles.
BoldJet’s ability to reduce operational costs, enhance safety, and minimize waste has earned it recognition as a CES 2025 Innovation Award honoree. FlowBeams aims to fundamentally change how we approach patient care, worker safety, and environmental responsibility, making a significant impact on global healthcare systems.
Article written by Mindy M. Hull
17/12/2024
Source:
EIN PressWire